Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients
Danay Saavedra, Beatriz García Verdecia, Patricia Lorenzo-Luaces, et al.
Cancer Immunology Immunotherapy (2015) Vol. 65, Iss. 1, pp. 37-45
Closed Access | Times Cited: 68

Showing 26-50 of 68 citing articles:

Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression
Yingyi Wang, Na Zhou, Rui Zhu, et al.
BMC Pulmonary Medicine (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Peripheral CD4+ naïve/memory ratio is an independent predictor of survival in non-small cell lung cancer
Peng Yang, Junhong Ma, Xin Yang, et al.
Oncotarget (2017) Vol. 8, Iss. 48, pp. 83650-83659
Open Access | Times Cited: 20
Selective effect of cytokine-induced killer cells on survival of patients with early-stage melanoma
Hong Li, Lan Huang, Linbo Liu, et al.
Cancer Immunology Immunotherapy (2016) Vol. 66, Iss. 3, pp. 299-308
Open Access | Times Cited: 15
Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer
Gisela María Suárez, Ana Laura Añé-Kourí, Amnely González, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 6, pp. 1735-1743
Open Access | Times Cited: 13
Sub-lethal doses of chemotherapeutic agents induce senescence in T cells and upregulation of PD-1 expression
Tetsuhiro Kasamatsu, Maaya Awata-Shiraiwa, Rei Ishihara, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 6, pp. 2695-2703
Open Access | Times Cited: 5
Evaluation of peripheral blood T lymphocyte surface activation markers and transcription factors in patients with early stage non-small cell lung cancer
Jacek Rutkowski, Marta Cyman, Tomasz Ślebioda, et al.
Cellular Immunology (2017) Vol. 322, pp. 26-33
Closed Access | Times Cited: 16
Biomodulina T partially restores immunosenescent CD4 and CD8 T cell compartments in the elderly
Danay Saavedra, Silvia A. Fuertes, Gisela María Suárez, et al.
Experimental Gerontology (2019) Vol. 124, pp. 110633-110633
Closed Access | Times Cited: 15
The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer
Tania Crombet Ramos, Orestes Santos Morales, Grace K. Dy, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12
Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer
Jie Zhang, Tianhui He, Zhongnan Yin, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Is Chronic Exposure to Low-Dose Organochlorine Pesticides a New Risk Factor of T-cell Immunosenescence?
Dong-Hee Ryu, Hee Tae Yu, Se-A Kim, et al.
Cancer Epidemiology Biomarkers & Prevention (2018) Vol. 27, Iss. 10, pp. 1159-1167
Closed Access | Times Cited: 12
Therapeutic vaccines for advanced non-small cell lung cancer
Marcela Cortés-Jofré, Rolando Uranga, Ania Torres Pombert, et al.
Cochrane library (2019)
Open Access | Times Cited: 12
Tumor microenvironment related novel signature predict lung adenocarcinoma survival
Juan Chen, Rui Zhou
PeerJ (2021) Vol. 9, pp. e10628-e10628
Open Access | Times Cited: 10
Immune senescence in non-small cell lung cancer management: therapeutic relevance, biomarkers, and mitigating approaches
Teodora Alexa‐Stratulat, Mariana Pavel, Vlad Andrei Cianga, et al.
Expert Review of Anticancer Therapy (2022) Vol. 22, Iss. 11, pp. 1197-1210
Closed Access | Times Cited: 6
<p>Changes and Clinical Significance of Detailed Peripheral Lymphocyte Subsets in Evaluating the Immunity for Cancer Patients</p>
Jinrong Qiu, Fuping Zhou, Xinchun Li, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 209-219
Open Access | Times Cited: 7
Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients
Patricia Lorenzo-Luaces, Lizet Sánchez, Danay Saavedra, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Cognitive impairment is related to a reduced count of T-lymphocytes in older patients diagnosed with non-small cell lung cancer (NSCLC)
Teresa Soria-Comes, V. Palomar Abril, Maria Martín Ureste, et al.
Translational Cancer Research (2020) Vol. 9, Iss. 11, pp. 6857-6866
Open Access | Times Cited: 7
Are There Reliable Biomarkers for Immunosenescence and Inflammaging?
Tamàs Fülöp, Alan A. Cohen, Glenn Wong, et al.
Healthy ageing and longevity (2019), pp. 231-251
Closed Access | Times Cited: 5
Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender
А. I. Stukan, R. A. Murashko, N. A. Tsygan, et al.
Head and neck tumors (HNT) (2022) Vol. 12, Iss. 3, pp. 114-126
Open Access | Times Cited: 3
Cancer, Ageing and Immunosenescence
Nora Manoukian Forones, Valquíria Bueno
Springer eBooks (2016), pp. 105-124
Closed Access | Times Cited: 2
Feasibility Study of a Novel Navigation System for Biopsy of Peripheral Lesions in the Lungs.
Gruionu Lg, Adrian Săftoiu, Radu-Teodoru Popa, et al.
PubMed (2016) Vol. 42, Iss. 1, pp. 76-81
Closed Access | Times Cited: 2
Onkoimmunologie im Alter
Marlene C. Wigand, S Jeske, Janina Hahn, et al.
HNO (2019) Vol. 68, Iss. 3, pp. 177-183
Closed Access | Times Cited: 3
The role of etiopathogenesis in shaping local immune responses in squamous cell oropharyngeal cancer
А. I. Stukan, Ольга Чухрай, S. D. Maksimenko
Voprosy Onkologii (2023) Vol. 69, Iss. 2, pp. 300-307
Open Access | Times Cited: 1
Treatment with the thymic polypeptide fraction Biomodulina T potentiates immune responses in older adults and cancer patients: an overview of the most recent studies
Danay Saavedra, Ana Laura A耖-Kour�Nuris Led髇, Tania Crombet, et al.
Deleted Journal (2024) Vol. 2, Iss. 1
Open Access
A Mendelian randomization study of the causal relationships between immune cells and colorectal cancer
HE Wei-hua, Lan He, Lan Deng
Research Square (Research Square) (2024)
Open Access
Identifying individual predictive factors for treatment efficacy
Ariel Alonso, Wim Van der Elst, Lizet Sánchez, et al.
Biometrics (2020) Vol. 78, Iss. 1, pp. 35-45
Open Access | Times Cited: 2

Scroll to top